Search Results - "Karameris, A."

Refine Results
  1. 1
  2. 2

    Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients by SCORILAS, A, KARAMERIS, A, ARNOGIANNAKI, N, ARDAVANIS, A, BASSILOPOULOS, P, TRANGAS, T, TALIERI, M

    Published in British journal of cancer (01-06-2001)
    “…Matrix metalloprotease-9 (MMP-9; 92 kDa type IV collaganase, gelatinase B) is regarded as, important for degradation of the basement membrane and extracellular…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis by Oikonomou, N, Thanasopoulou, A, Tzouvelekis, A, Harokopos, V, Paparountas, T, Nikitopoulou, I, Witke, W, Karameris, A, Kotanidou, A, Bouros, D, Aidinis, V

    Published in Thorax (01-06-2009)
    “…Despite intense research efforts, the aetiology and pathogenesis of idiopathic pulmonary fibrosis remain poorly understood. Gelsolin, an actin-binding protein…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Elevated serum levels of the apoptosis related molecules TNF-α, Fas/Apo-1 and Bcl-2 in oral lichen planus by Sklavounou-Andrikopoulou, A., Chrysomali, E., Iakovou, M., Garinis, G. A., Karameris, A.

    Published in Journal of oral pathology & medicine (01-08-2004)
    “…Background:  The serum circulatory levels of apoptosis related molecules measured in patients with oral lichen planus (OLP) and healthy individuals in order to…”
    Get full text
    Journal Article
  10. 10

    Cellular immunophenotyping of exfoliative dermatitis in canine leishmaniosis ( Leishmania infantum) by Papadogiannakis, E.I., Koutinas, A.F., Saridomichelakis, M.N., Vlemmas, J., Lekkas, S., Karameris, A., Fytianou, A.

    Published in Veterinary immunology and immunopathology (08-04-2005)
    “…Lymphocyte subsets, major histocompatibility complex (MHC)-II expressing cells and number of amastigotes in the epidermis and dermis were investigated…”
    Get full text
    Journal Article
  11. 11

    Large intraparotid facial nerve schwannoma: Case report and Review of the Literature by Salemis, N.S, Karameris, A, Gourgiotis, S, Stavrinou, P, Nazos, K, Vlastarakos, P, Tsiambas, E, Tsohataridis, E

    “…Abstract Here is reported an extremely rare case of a large intraparotid facial nerve schwannoma in a 32-year-old female who presented with a parotid mass…”
    Get full text
    Journal Article
  12. 12

    c-MYC and h-TERT co-expression in colon adenocarcinoma: a tissue microarray digitized image analysis by Georgakopoulos, G, Tsiambas, E, Korkolopoulos, P, Korkolopoulou, P, Kavantzas, N, Karameris, A, Ragkos, V, Rigopoulos, D N, Vilaras, G, Patsouris, E, Athanasiou, A E, Tatsiou, D

    Published in Journal of B.U. ON. (01-01-2013)
    “…c-MYC oncogene is frequently deregulated by amplification in colon adenocarcinoma. c-MYC also activates telomerase by inducing expression of its catalytic…”
    Get more information
    Journal Article
  13. 13

    Prognostic impact of HER2/neu protein in urothelial bladder cancer. Survival analysis of 80 cases and an overview of almost 20 years' research by Skagias, L, Politi, E, Karameris, A, Sambaziotis, D, Archondakis, A, Vasou, O, Ntinis, A, Michalopoulou, F, Moreas, I, Koutselini, H, Patsouris, E

    Published in Journal of B.U. ON. (01-07-2009)
    “…This study was conducted to evaluate the quantitative assessment of HER2/neu immunohistochemical expression in urothelial bladder cancer in order to determine…”
    Get more information
    Journal Article
  14. 14

    Evaluation of epidermal growth factor receptor gene and chromosome 7 alterations in squamous cell carcinoma of the larynx, using chromogenic in situ hybridization on tissue microarrays by Tsiambas, E, Stavrakis, I, Lazaris, A C, Karameris, A, Patsouris, E

    Published in Journal of laryngology and otology (01-06-2007)
    “…To identify subgroups of patients with squamous cell carcinoma (SCC) of the larynx, characterized by the specific deregulation mechanism of the epidermal…”
    Get more information
    Journal Article
  15. 15

    Gene numerical imbalances in cytological specimens based on fluorescence/chromogenic in situ hybridization analysis by Tsiambas, E, Karameris, A, Lygeros, M, Athanasiou, A E, Salemis, N S, Gourgiotis, S, Ragkos, V, Metaxas, G E, Vilaras, G, Patsouris, E

    Published in Journal of B.U. ON. (01-07-2012)
    “…Design and development of novel targeted therapeutic strategies is an innovation in handling patients with solid malignancies including breast, colon, lung,…”
    Get more information
    Journal Article
  16. 16

    Targeting topoisomerase IIa in endometrial adenocarcinoma: a combined chromogenic in situ hybridization and immunohistochemistry study based on tissue microarrays by Tsiambas, E, Alexopoulou, D, Lambropoulou, S, Gerontopoulos, K, Karakitsos, P, Karameris, A

    “…Topoisomerase IIa is a nucleic enzyme that affects the topological structure of DNA and also is a target for chemotherapy (ie, anthracyclines). In this study,…”
    Get more information
    Journal Article
  17. 17
  18. 18

    The Bcl-2/Bax system and apoptosis in ulcerative colitis by Karamanolis, D G, Kyrlagkitsis, Ioannis, Konstantinou, K, Papatheodoridis, G V, Karameris, A, Mallas, E, Ladas, S D, Raptis, S

    Published in Hepato-gastroenterology (01-06-2007)
    “…Ulcerative colitis (UC) constitutes a chronic inflammatory process of the colon of unknown etiology. Current data support a pivotal role of apoptosis in the…”
    Get more information
    Journal Article
  19. 19

    Deregulation of EGFR/VEGF/HIF-1a signaling pathway in colon adenocarcinoma based on tissue microarrays analysis by Rigopoulos, D N, Tsiambas, E, Lazaris, A C, Kavantzas, N, Papazachariou, I, Kravvaritis, C, Tsounis, D, Koliopoulou, A, Athanasiou, A E, Karameris, A, Manaios, L, Sergentanis, T N, Patsouris, E

    Published in Journal of B.U. ON. (01-01-2010)
    “…Overexpression of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) in colon adenocarcinoma (CA) is a frequent event,…”
    Get more information
    Journal Article
  20. 20